Among them, CDKN2A, a tumor suppressor gene that encodes for p16INK4A and p14ARF, critical for the regulation of cell cycle pathways (70, 71), was also a well-known biomarker in PAAD and a member of the 10 Cuproptosis-related genes meanwhile. This evidence concerns the gene CDKN2A and pancreatic adenocarcinoma.